Almost 70% of eligible executives participated in nonqualified defined contribution plans in 2025, according to the Plan Sponsor Council of America. Participation in nonqualified defined contribution ...

Full Year Revenue Up 52% and EPS Up 135% Attributable to Acquisition, Integration Nearly Complete, 2026 Outlook Expects YoY ...

Full Year Revenue Up 52% and EPS Up 135% Attributable to Acquisition, Integration Nearly Complete, 2026 Outlook Expects YoY Growth in Revenue, Profitability and Free Cash Flow, Significant Opportuniti ...

Wage inequality is rising. According to Investopedia, the ratio of CEO pay to average worker pay in 2025 was 348-to-1. The Economic Policy Institute (EPI) puts that number at 281 in 2024 compared with ...

Welcome to Talking T&E for Advisors, where Trusts & Estates Editor in Chief Susan Lipp and Jamie Hopkins, chief wealth officer at Bryn Mawr Trust, take seemingly complex estate planning issues and ...

Discover how the Thrift Savings Plan (TSP) offers tax advantages and investment options for federal employees, similar to a ...

Q4 2025 Earnings Call March 5, 2026 11:00 AM ESTCompany ParticipantsAl Petrie - Officer of Investor RelationsPaul McKinney - ...

The latest company to reflect that ethos? Dell, which is shaking up how it pays its sales team to more sharply penalize underperformers, Business Insider reports. Per an internal presentation viewed ...

Q4 2025 Net Revenue of $128.6 million - Pro Forma Full Year 2025 Net Revenue of $401.3 million - Q4 2025 Net Income of $14.0 million; Adjusted EBITDA of $77.2 million - Conference Call Scheduled for ...

NEW YORK & TEL AVIV, Israel, February 09, 2026--monday.com (NASDAQ: MNDY), the AI work platform that turns strategy into execution, at scale, today reported financial results for its fourth quarter ...

Palladyne AI Corp. (NASDAQ:PDYN) Q4 2025 Earnings Call Transcript March 5, 2026 Palladyne AI Corp. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.09. Operator: ...

Standard BioTools Inc. (NASDAQ: LAB) (the 'Company” or 'Standard BioTools”) today announced financial results for the quarter and fiscal year ended December 31, 2025.